Olon Biotech division launched
18th July 2022
Submitted by:
Andrew Warmington
Italian firm Olon has presented its new division, Olon Biotech, which will offer CDMO services at industrial scale. These based on microbial fermentation processes using bacteria, yeast and fungi and will include high potency. It will also have proprietary products for industries including health and pharma, food, cosmetics, flavours and fragrances.
Olon Biotech is based around the two multi-purpose ‘bio-hubs’ at Settimo Torinese and Capua, in which the company has invested around €80 million in recent years. This, the firm said, has led significant increase in capacity and added new purifications departments. Some 675 people work in these bio-hubs.